Friday, October 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryunregulated peptidespatient safetyajmc

Physician warns unregulated peptide side effects are easy to miss

Obesity medicine specialist Catherine Varney, DO, tells AJMC that adverse effects from unregulated peptide products often go unrecognized in clinical settings.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 2 13:29 ETSource: AJMC

The wire

  1. 01In an AJMC interview, Catherine Varney, DO, says side effects tied to unregulated peptide use are frequently missed by clinicians.
  2. 02Clinicians taking medication histories may not hear about gray-market peptide use unless they ask directly, leaving adverse events unattributed.
  3. 03The item is an interview rather than new data, and no incidence figures or case series were presented.

From the source

Unregulated Peptide Side Effects Easy to Miss: Catherine Varney, DO

Read at ajmc.com
PeptiPrescribed peptides from $99/moSee all →